Tirzepatide, the novel medication, is generating considerable excitement within the scientific community. It operates differently from common diabetes medications, targeting multiple receptors involved in blood regulation and hunger . Initial studies have demonstrated remarkable efficacy in lowering blood glucose in individuals with diabetes of the